CWP
FLGT icon

Concord Wealth Partners’s Fulgent Genetics FLGT Stock Holding History

Concord Wealth Partners’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-34
Closed -$909 – 886
2023
Q3 		$909 Sell
34
-23
-40% -$785 ﹤0.01% 952
2023
Q2 		$2.11K Hold
57
– – ﹤0.01% 855
2023
Q1 		$1.78K Hold
57
– – ﹤0.01% 830
2022
Q4 		$1.7K Buy
+57
New +$2.04K ﹤0.01% 977

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Concord Wealth Partners's FLGT Position: Q4 2023 in Review

Concord Wealth Partners sold out of Fulgent Genetics (FLGT) in Q4 2023, closing a stake of 34 shares — an estimated $909 sold.

Concord Wealth Partners first reported a position in FLGT in Q4 2022 and held it in 4 quarters. The position peaked at $2.11K in Q2 2023. 196 funds tracked by Wall St. Rank hold FLGT as of Q4 2023.

  • Concord Wealth Partners reported no remaining Fulgent Genetics position as of Q4 2023 after selling out during the quarter.
  • Concord Wealth Partners sold 34 Fulgent Genetics shares in Q4 2023, an estimated $909.
  • Concord Wealth Partners first reported a position in Fulgent Genetics in Q4 2022 and held it in 4 quarters.
  • Concord Wealth Partners's Fulgent Genetics position peaked at $2.11K in Q2 2023.
  • 196 funds tracked by Wall St. Rank held Fulgent Genetics as of Q4 2023.

Based on Concord Wealth Partners's 13F filing for Q4 2023, filed 6 Feb 2024.